Atea Pharmaceuticals Inc (AVIR)
SG&A Expense Growth
1.09%
Quarterly · Period ending:
AVIR SG&A Expense Growth
Latest reported1.09%period ending
Latest reported1.09%period ending
AVIR Quarterly SG&A Growth (QoQ) (0.00% → 1.09%)
Latest values, visible window
High-resolution chart · PNG
AVIR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 1.0911% | |
| -3.4008% | |
| -1.4404% | |
| -20.3969% | |
| -4.0922% | |
| -28.6318% | |
| 19.9946% | |
| -8.8561% | |
| -0.0907% | |
| 6.1537% | |
| -9.3621% | |
| -4.3122% | |
| 4.4154% | |
| 2.0714% | |
| 8.641% | |
| -8.531% | |
| -0.8372% | |
| -4.8984% | |
| 10.4615% | |
| 0.3193% | |
| 35.8717% | |
| -38.0552% | |
| 251.0427% | |
| 79.1815% | |
| 84.2623% | |
| -2.8662% | |
| -7.511% | |
| 52.2422% | |
| -3.8793% | |
| 0% |